Gyre Therapeutics
GYRE
#5535
Rank
โ‚ฌ0.96 B
Marketcap
11,22ย โ‚ฌ
Share price
-8.99%
Change (1 day)
-3.77%
Change (1 year)

Revenue for Gyre Therapeutics (GYRE)

Revenue in 2024 (TTM): โ‚ฌ79 Million

According to Gyre Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ81.5 Million. In 2023 the company made a revenue of โ‚ฌ0.10 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ14.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gyre Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ79 M-27.07%
2023 โ‚ฌ0.10 B664.94%
2022 โ‚ฌ14.16 M5.49%
2021โ‚ฌ13.42 M